dr. bekaii saab on the role of immunotherapy in crc
Published 7 years ago • 73 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
3:29
tanios bekaii-saab md, facp, considers the emerging role of immunotherapy in advanced crc treatment
-
1:28
dr. bekaii-saab on the response rate of pembrolizumab in msi-h crc
-
0:46
dr. bekaii saab on immunotherapeutic options in crc beyond pd-1/pd-l1
-
1:49
dr. bekaii-saab on immunotherapy in colorectal cancer
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
1:55
dr. bekaii-saab on challenges with precision medicine in crc
-
0:57
dr. bekaii-saab on the importance of the redos study in mcrc
-
1:49
dr. bekaii-saab on resistance to targeted therapy in crc
-
0:58
dr. morris on the role of immunotherapy in metastatic crc
-
2:06
dr. bekaii-saab on the impact of the beacon crc study in braf-mutated crc
-
1:13
dr. bekaii-saab on the addition of atezolizumab to capecitabine/bevacizumab in mss mcrc
-
9:02
pembrolizumab in msi-h crc tumors
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:39
dr. bekaii-saab on microsatellite instability in colorectal cancer
-
7:00
sequencing considerations in mss crc tumors
-
3:47
dr bekaii-saab on the future of treatment for patients with gi cancer
-
1:19
dr. bekaii-saab on second-line treatment options in hcc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
2:42
dr. bekaii-saab discusses an analysis of bevacizumab or cetuximab for crc